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Summary 
Patients with the genetic disorder ataxia telangiectasia 
(AT) have mutations in the AT mutated (ATM) gene, 
which is homologous to TEL1 and the checkpoint gene 
MEC1. A tell deletion mutant, unlike a mecl deletion, 
is viable and does not exhibit increased sensitivity to 
DNA-damaging agents. However, increased dosage of 
TEL1 rescues sensitivity of a mecl mutant, mecl-1, to 
DNA-damaging agents and rescues viability of a mecl 
disruption, mecl.1 tellA1 double mutants are syner- 
gistically sensitive to DNA-damaging agents, includ- 
ing radiomimetic drugs. These data indicate that TEL 1 
and MEC1 are functionally related and that functions 
of the ATM gene are apparently divided between at 
least two S. cerevisiae homologs. 
Introduction 
Ataxia telangiectasia (AT) is an autosomal recessive disor- 
der characterized by progressive cerebellar ataxia, dilated 
blood vessels in the eyes and skin (oculocutaneous tel- 
angiectasias), cellular and humoral immune deficiencies, 
hypersensitivity to ionizing radiation, and increased pre- 
disposition for leukemias and lymphomas (reviewed by 
Friedberg et al., 1995; Shiloh, 1995). The incidence of AT 
is estimated at one in 40,000 to one in 100,000 live births. 
These homozygous patients are approximately 100 times 
more likely to develop cancer than the general population 
(Morrell et al., 1986). AT heterozygous carriers, who repre- 
sent approximately 1% of the population (Swift et al., 
1986), reportedly have a 3- to 4-fold increase in cancer 
predisposition (Swift et al., 1991). 
Cell lines derived from AT patients exhibit higher levels 
of chromosome breakage, rearrangement, and loss, a re- 
duced life span in culture, higher requirements for serum 
growth factors, and defects in the cytoskeletal actin fibers 
(reviewed by Shiloh, 1995). AT cells also demonstrate in- 
creased sensitivity to ionizing radiation (Taylor et al., 1975) 
and radiomimetic hemicals (McKinnon, 1987), as well as 
resistance to inhibition of DNA synthesis (radioresistant 
DNA synthesis) after ionizing radiation (Painter, 1985). 
This evidence suggests that AT cells might be deficient 
in their ability to arrest or delay the cell cycle following 
DNA damage (Painter et al., 1982; Kastan et al., 1992). 
Amino acid sequence comparison of the product of the 
recently cloned gene mutated in AT (ATM) (Savitsky et al., 
1995) shows significant homology of the carboxyl terminus 
to lipid kinases, particularly phosphatidylinositol 3-kinases 
(PI3Ks). In mammalian cells, PI3Ks are involved in gener.. 
ating early signals required for mitogenesis, as well as 
regulating the actin cytoskeleton (reviewed by Fry, 1994), 
in which AT patients have known defects. In the budding 
yeast, Saccharomyces cerevisiae, several genes have 
been identified with putative lipid kinase domains, includ- 
ing MEC1/ESR1 (Weinert et al., 1994; Kato and Ogawa, 
1994), TOR 1/DRR1 and TOR2/DRR2 (Heitman et al., 1991 ; 
Cafferkey et al., 1993; Kunz et al., 1993; Brown et al., 
1994), and VPS34 (Herman and Emr, 1990; Schu et al., 
1993), as well as an uncharacterized open reading frame 
(ORF), YBL088 (Feldmann et al., 1994). Since a deletion 
of VPS34 eliminates all detectable PI3K activity, it is likely 
that the other lipid kinase-containing proteins phosphory- 
late inositol in a different position (Schu et al., 1993) or 
possibly even lack lipid kinase activity. The other S. cere- 
visiae homologs, MEC1/ESR1, TOR1/DRR1, and TOR2! 
DRR2, all appear to function in cell cycle regulation. MEC1/ 
ESR1, an essential gene, was originally identified by Wei- 
nert et al. (1994) in a genetic screen for mutants (mecl-1) 
that exhibit a rapid death phenotype after shifting to non- 
permissive temperatures in a cdc13 mutant background. 
MEC1/ESR1 was independently cloned by Kato and Ogawa 
(1994) in a screen for mutants that are sensitive to methyl 
methanesulfonate and defective in meiotic recombination. 
It is apparent, therefore, that MEC1 is not only required 
for cell cycle delay or arrest at both S and G2 in response 
to DNA damage, and for proper meiosis, but has other 
essential, currently unknown functions (Weinert et al., 
1994; Kato and Ogawa, 1994). The homologs TOR1/DRR1 
and TOR2/DRR2, identified in screens for rapamycin- 
resistant yeast strains, have also been shown to be re- 
quired for G1 progression (Kunz et al., 1993; Brown et al., 
1994). tor2 mutants appear to arrest randomly in the cell 
cycle, but torl tor2 double mutants arrest in G1 (Kunz et 
al., 1993). It was suggested that TOR1 and TOR2 might be 
components of a signal transduction pathway that interact 
with G 1 cyclins, similar to the interleukin-2 signal transduc- 
tion pathway of T cells. 
Our primary purpose in initiating these studies was to 
use yeast as a model system for studying the cellular phe- 
notypes found in AT patients. In particular, we focused on 
the unknown ORF (YBL088) because it was more homolo- 
gous to ATM than any of the other lipid kinases currently 
in the sequence data bases. (After completion of the work 
presented here, we learned that YBL088 is equivalent o 
TEL1 [Greenwell et al., 1995 Ithis issue of Cell~], originally 
isolated in a screen for mutants [tell-l] having short telo- 
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meres [Lustig and Petes, 1986].) TEL1 and MEC1 also 
contain a region of homology to the Schizosaccharomyces 
pombe gene rad3, which is required for G2 arrest after 
DNA damage (Seaton et al., 1992). It is this rad3 homology 
that distinguishes ATM, TEL1, and MEC1 from the other 
lipid kinase genes. The finding that tell-1 has telomere 
defects is particularly intriguing in light of the potential 
telomere defects identified in AT patient cell lines (Pandita 
et al., 1995). In this study, we demonstrate that TEL1 is 
functionally related to MECI. Our finding is based on TEL1 
rescue of mecl-1 sensitivity to DNA-damaging agents. In 
addition, we show that TEL1 can substitute for the essen- 
tial function(s) provided by MEC1 and that mecl-1 tellA 1 
double mutants are synergistically sensitive to ionizing ra- 
diation, ultraviolet light (UV), hydroxyurea (HU), and radio- 
mimetic drugs. We suggest that TEL1 and MEC1 function 
in redundant checkpoint pathways and that functional 
analysis of the phenotypes of AT cells may be aided by 
studying the S. cerevisiae ATM homologs, TEL1 and MEC1. 
Results 
Human ATM Is Most Homologous 
to S. cerevisiae TEL1 
Basic local alignment search technique protein (BLASTP; 
Altschul et al., 1990) computer analysis of the complete 
3056 amino acid ATM sequence (K. Savitsky, personal 
communication) demonstrates that TEL1 is significantly 
more homologous to ATM than any other gene currently 
sequenced (BLASTP score of 10 -91 for Tel lp compared 
with 10 -~9 for Meclp). The original BLASTP analysis of a 
partial A TM clone 7-9 (Savitsky et al., 1995) also showed 
greatest homology to TEL1, previously annotated as an 
uncharacterized ORF(YBL088). In addition, of the 14ATM 
patient mutations equenced, seven were frameshift run- 
cations (three are shown in Figure 1A), one was a deletion, 
and six (representing four families) were small in-frame 
deletions (Figure 1B; Savitsky et al., 1995). These six in- 
frame deletions fell into one of three categories dia- 
grammed in Figure lB. Three-way alignments of the corre- 
sponding amino acid sequences from these patients 
shows that in two of the three cases a residue conserved 
between ATM and Tellp, but not between ATM and 
Meclp, is deleted (Figure 1B). We conclude from this and 
the BLASTP scores that ATM is more similar to TEL1 than 
to MEC1. 
Deletion of TEL1 Does Not Increase Sensitivity 
to DNA-Damaging Agents 
A complete and precise deletion of the TEL10RF was 
generated using the deletion technique of Baudin et al. 
(1993) (Figure 2A; see Experimental Procedures). The 
wild-type diploid strain YPH274 was transformed with the 
appropriate polymerase chain reaction (PCR) product, 
and His + colonies were selected. The heterozygous te/1 
deletion strain (YDM881, telIAI::HIS3/TEL1), as verified 
by both Southern blotting and PCR analysis, was sporu- 
lated, and spore viability was determined. All four spores 
grew equally well (data not shown), indicating that TEL1 
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Figure 1. Schematic of Frameshift Truncation and In-Frame Deletions 
in AT Patients 
(A) Schematic of ATM, TEL1, and MEC1 full-length clones depicting 
the rad3 and PI3K (Ptdlns(3)) domains. Frameshift runcation muta- 
tions from three AT patients are indicated (asterisks). Corresponding 
truncations were generated in both TEL1 and MEC1 (see also Figure 
2A). Small in-frame deletions identified in A TM are also indicated (open 
triangles). 
(B) Alignment of the in-frame deletions from six AT patients (AT3NG, 
AT1ABR and AT2ABR, AT2BR, AT5BI, and AT6BI) with corresponding 
sequence from TEL1 and MEC1. Deleted amino acids are boxed. 
is not an essential gene and that deletion of TEL1 has no 
obvious effect on growth. 
One of the major clinical features of AT is sensitivity 
to a variety of DNA-damaging agents, including ionizing 
radiation and radiomimetic drugs. The haploid tellA1 
strain (YDM884)as well as homozygous (YDM890, tellA 1/ 
tell A 1) and heterozygous (YDM881, tell A 1~-I-EL1) diploid 
strains were tested for sensitivity to ionizing radiation, sev- 
eral radiomimetic drugs (bleomycin and streptonigrin), and 
the drug ethyl methanesulfonate. No significant difference 
in viability was observed between wild-type and tell mu- 
tant strains after exposure to ionizing radiation (Figure 
3) or after radiomimetic drug treatment (data not shown), 
although a 2- to 3-fold reduction in viability of tellA 1 was 
observed at high concentrations (4.5%) of ethyl methane- 
sulfonate (data not shown). These data suggest that a 
complete deletion of TEL1 does not mimic these particular 
AT phenotypes. The tellA 1 null mutant was also tested for 
sensitivity to both UV and HU, since MEC1/ESR1 mutants 
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Figure 2. Schematic of tel l  Deletion Strains and Gap Repair of the 
TEL1 Gene 
(A) PCR primer sequence was determined (see Table 3 for primer 
sequence) based on corresponding regions of homology between A TM 
and TEL1 (see also Figure 1A). Primers contained a region of homol- 
ogy to pRS (indicated by arrows). Primers 5, 6, and 7 contain the TAA 
termination codon (asterisks). pRS303 (HIS3) vector was amplified with 
the indicated primers and transformed into YPH274. The resulting tel l  
truncation mutants are listed and schematically diagrammed. 
(B) YDM881 (tel IAI: :HIS3/TEL1 heterozygous train) genomic DNA 
was amplified using primers 1 and 4 flanking the wild-type TEL1 gene. 
The resulting 3.2 kb PCR product was gel purified, digested with EcoRI 
and Spel, and subcloned into pRS316. The resulting gap repair plas- 
mid was linearized with the EcoR47111 unique to the HIS3 gene and 
transformed into wild-type (YPH274) yeast. Ura ÷ transformants were 
replica plated onto synthetic media lacking histidine, and Ura- His 
transformants were selected for further analysis. Genomic DNA from 
Ura + His strains was isolated and transformed into bacteria. Bacteria 
containing successfully gap-repaired plasmid grew slowly. 
(mecl-1 and esrl-1, respectively), but not AT cells, exhibit 
sensitivity to these treatments. No significant difference 
in viability compared with wild type was observed (data 
not shown). 
One of the most intriguing features of the mutations 
found to date in AT patients is the preponderance of 
frameshift mutations that result in premature termination 
of the protein (Savitsky et al., 1995; K. Savitsky, personal 
communication). We therefore tested truncation muta- 
tions of MEC1 and TEL1 for potential dominant interfering 
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Figure 3. tell  Deletion StrainsAre Not Sensitive to Ionizing Radiation 
Wild-type diploid (YPH274) or haploid (YDM885) strains, heterozygous 
(YDM881) or homozygous (YDM890) diploid tell  deletion strains, 
te l lA 15LA truncation mutant (YDM950) strain, or mecl -1  (TWY308) 
mutant strain were grown to middle-log phase and exposed to ionizing 
radiation at the doses indicated. Equal numbers of cells were plated, 
and cell viability was determined 2 days later. Standard deviations are 
shown using two to fou r samples. The experiment was performed three 
times with similar results. 
effects with normal checkpoint function (see Figures 1A 
and 2A). All three truncation mutants of tell were viable, 
and no increase in sensitivity to ionizing radiation (see 
telIA15LA in Figure 3), UV, or HU was observed (data 
not shown), whereas all three truncation mutants of mecl  
were inviable. These data suggest that tru ncation mutants 
of TEL1 do not exhibit a dominant interfering phenotype. 
Cloning the TEL1 Gene 
Despite observing no apparent sensitivity to ionizing radia- 
tion in tell mutants, we hypothesized that since Tellp and 
Meclp are homologous (48% similar and 22% identical), 
they might be functionally related or partially redundant 
proteins. To test this hypothesis it was necessary to clone 
the TEL 1 gene. We first attempted to clone TEL 1 by screen- 
ing a LEU2/CEN genomic library, but were unable to obtain 
any full-length clones (see Experimental Procedures). It 
appeared that several DNA inserts had undergone re- 
arrangements, perhaps because the TELl-containing plas- 
raids were toxic to the bacteria. 
To clone the gene successfully, we devised a gap repair 
strategy (see Figure 2B) taking advantage of the tellA 1:: 
HIS3 locus. A PCR product spanning this region was gen- 
erated and subcloned into the URA/CENplasmid, pRS316. 
This gap repair vector was linearJzed by digesting within 
the HIS3 gene using EcoR47111 and transformed into wild- 
type yeast cells. Double-strand gap repair between se- 
quences flanking the HIS3 gene on the plasmid and the 
endogenous sequences flanking TEL1 resulted in gene 
replacement of HIS3 with TELl. Plasmids were recovered 
Cell 
834 
mecl -1  + pRS316 mecl -1  + pDM197 
X-ray 
HU 
IOO~ 
E 
A 
>, 
d,== 
• -- 10. 
.O  
¢U 
.B  
% 
\ , \  
----o-- TWY397 (vild-type) \~ 
.... o .... TWY30$ (mec1.1) + pRS316 "..%T 
--O-- TWY308 (m~cl-l) + pDMI97 i 
1 
Gamma Irradiation Dose (krads) 
- j ................ 
. -1 .  ~ ~ X 
o.1. ~ '=.. \ 
OOl 
UV Dose ( J /m 2) 
Figure 4. TEL1 Rescues mecl-1 Sensitivity to Ionizing Radiation, UV, 
and HU 
by transformation with yeast genomic DNA into bacteria. 
Bacteria transformed with successfully gap-repaired plas- 
mid grew slowly, supporting the possibility that TEL1 is 
toxic in bacteria. Subsequent comparison of restriction 
patterns with that predicted by the genomic sequence indi- 
cated that the complete TEL 1 gene plus flanking sequence 
was present (termed pDM197). 
TEL1 Is Functionally Related to MECl 
To test our hypothesis that TEL1 and MEC1 might be func- 
tionally related, we used cross-complementation studies 
with the mecl-1 mutant. The mecl-1 strain was trans- 
formed with either vector alone (pRS316) or the TEL 1-co n- 
taining URA3/CEN plasmid (pDM197). Figure 4A shows 
that 32 kR of ionizing radiation killed most mecl-1 cells 
containing the plasmid control. However, mecl-1 trans- 
formed with pDM197 showed healthy colony growth after 
irradiation (Figure 4B). The percentage of viable cells after 
irradiation is similar to that observed with wild type (Figure 
4E), although complete rescue of viability was not ob- 
tained. This suggests that increased expression of TEL1 
at CEN copy levels cannot fully compensate for mecl - l .  
Similar results were also seen when cells were exposed 
to UV (Figure 4F). Increasing doses of UV cause rapid 
death of mecl-1 containing the plasmid control, but CEN- 
level expression of TEL1 was capable of rescuing viability 
to near wild-type levels. At 60 Jim 2, for example, only 0.1% 
of mecl-1 cells are viable; however, with the TELl-con- 
taining plasmid approximately 15%-20% of the cells sur- 
vive. This is similar to the 30%-40% survival for wild-type 
strains. Even at higher UV doses, the viability was close 
to wild type. 
The ability of the TELl-containing plasmid to rescue the 
mecl-  1 mutant sensitivity to H U was also tested. Wild-type 
cells are normally able to delay in S phase in the presence 
of HU, but the mecl-1 mutant does not and is thus ex- 
tremely sensitive to HU treatment (Weinert et al., 1994; 
Kato and Ogawa, 1994). It is presumed that inviability of 
mecl-1 in the presence of HU results from cells entering 
mitosis without fully replicated DNA. mecl-1 cells treated 
for 4 hr in 0.1 M HU show a log phase-type distribution 
of small budded and large budded cells, as well as high 
inviability, whereas wild-type cells virtually all delay with 
a large bud, and most cells remain viable. This is consis- 
tent with MEC1 being directly involved in an S phase- 
specific checkpoint (Weinert et al., 1994; Kato and Ogawa, 
1994). Figu re 4D shows that mec 1-1 cells transformed with 
pDM197 exhibit healthy colony growth 24 hr after expo- 
sure to HU treatment. Viability is similar to that seen in 
wild-type cells after such treatment (data not shown). 
A plasmid control, pRS316 (A and C), or a TELl-containing URA/CEN 
plasmid, pDM197 (B and D), was transformed into the mecl-1 
(TWY308) strain. The resulting strains were exposed to 32 kR of ioniz- 
ing radiation (A and B) or 0.1 M HU for 4 hr (C and D). Photographs of 
colonies were taken 24 hr later. To determine the efficiency of pDM197 
rescue, we determined viability after xposure to increasing dosage 
of ionizing radiation (E) or UV (F). Standard eviations are shown 
using two to four samples. Experiments were performed two times 
with similar esults. 
TEL 1 Is Functionally Related to MEC1 
835 
I00~. T 
'\", 1 
~ ....... TWY308 (re,c1-1) 
~ ............ YDM936 (t~lZAZ me¢1-1 • - .  ¢ 
- -~a .... YDM937 ( te l lA1  mec l -1  
,% 
.. ,%% 
OA . . . .  
Oanuna Irradiation Dose (kinds) 
|00 
B 
;> 
&1 
&Of 
S~m 
Figure 5. Synergistic Sensitivityto Ionizing Radiation, HU, and Radio- 
mimetic Drugs in mecl-1 tellA 1 Double Mutants 
(A) YPD plates of wild-type (YDM911 and TWY397), mecl-1 (TWY308), 
TEL1 Rescues the Essential Function of MECl  
MEC1 is required not only for both S phase and G2 check- 
point functions, but is also essential for viability, sug- 
gesting functions other than checkpoint maintenance 
(Weinert et al., 1994; Kato and Ogawa, 1994). The pDM197 
vector was transformed into the heterozygous YDM966 
MEC1 strain, mec l A 15LA: :HIS3/MEC1 (mec l A 15LA is an 
inviable deletion derivative lacking the last 1215 amino 
acids of the 2368 amino acid Mecl p ORF, including the 
PI3K domain). Tetrad analysis demonstrated that pDM 197 
rescued the inviability of the mecl  truncation mutant. 
These spores were all His + Ura ÷, and subsequent loss of 
the plasmid, as assayed by plating the cells on 5-fluoro- 
erotic acid (Boeke et al., 1984), caused death (data not 
shown). This suggests that an extra copy of TEL1 can pro- 
vide the essential functions normally provided by MECI .  
Synergistic Interaction between tel lA1 
and mecl.1 
Although the data provided thus far demonstrate that an 
extra copy of TEL1 can rescue both the mecl - I  sensitivity 
to DNA-damaging agents and inviability of the mecl  trun- 
cation mutant, there is no direct evidence that TEL1 is 
required for checkpoint function. We hypothesized that if 
TEL1 plays a role in checkpoint control, a te/1A 1 mec l -1  
double mutant might be more sensitive to DNA-damaging 
agents. Double mutant strains were generated by a genetic 
cross between mecl -1  (TWY308) and te/1A 1 (YDM884). 
Four independent mecl-1 te/1A 1 double mutants (YDM935, 
YDM936, YDM937, and YDM938) were selected for fur- 
ther study. All four double mutant strains grew less well 
than wild-type strains and grew extremely poorly at 37°C 
(data not shown). When the double mutants were tested for 
sensitivity to ionizing radiation (Figure 5A), all four double 
mutants died at very low doses. When approximately 1500 
cells were plated for each of the four double mutants, not 
a single cell survived a low dose (10 kR) of radiation and 
only 2%-4% survived after 5 kR of radiation:; examples 
(YDM936 and YDM937) are shown in Figure 5A. This con- 
trasts with a dose of 32 kR required for essentially 100% 
killing of the mecl -1  mutant and 200 kR for a wild-type 
or tellA 1 mecl-1 double mutant (YDM936 and YDM937) strains were 
exposed to increasing doses of ionizing radiation. Colony-forming units 
were determined 2-3 days later, and viability was determined by com- 
paring irradiated plates with unirradiated control plates. 
(B) Wild-type (YDM911), mecl-1 (TWY308), or tellA 1 mecl-1 double 
mutant (YDM935) strains were grown in 0.1 M HU for 4 hr at 30°C. 
Cells were counted and plated onto YPD plates. Colony-forming units 
were counted 2-3 days later. Viability of a tellA1 mutant (data not 
shown) was equivalent towild type. 
(C-E) mecl-1 tellA 1 double mutants were replica plated onto YPD 
plates containing streptonigrin or bleomycin (plus) or control plates 
lacking drugs (minus). Only representative double mutants are shown. 
(C) tellA 1 mecl-1 (YDM936) treated with (plus) and without (minus) 
streptonigrin (0.5 gg/ml). (D)tellA 1 mecl-1 (YDM938) with (plus) and 
without (minus) Neomycin (10 i~g/ml). (E)mecl-1 (TWY308)with (plus) 
and without (minus) streptonigrin. No effect on wild type or either the 
tellA 1 or mecl-1 mutant alone was observed at the highest concentra- 
tions of streptonigrin or Neomycin tested. Standard deviations are 
shown using two to four samples for (A) and (B). Experiments were 
performed two times with similar results. 
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yeast strain (data not shown). It appears, therefore, that 
TEL1 provides either a basal level of checkpoint surveil- 
lance or repair. Synergism in sensitivity to the S phase- 
specific drug H U was also tested in all four double mutants. 
These mutants were extremely sensitive to 4 hr of 0.1 M 
HU treatment. A representative double mutant (YPH935) 
is shown in Figure 5B. Of approximately 5000 cells plated 
for each of the four double mutants, not a single cell sur- 
vived. This contrasts with a survival rate of about 1% for 
the mecl-1 mutant (TWY308) and 50%-60% for wild type 
(YDM911). The tellA 1 strain had viability levels equivalent 
to those of wild-type cells (data not shown). The double 
mutants were also more sensitive to UV treatment han 
wild type or either te l lA l  MEC1 or TEL1 mecl-1 single 
mutants (data not shown). These data indicate a genetic 
interaction between TEL1 and MEC1. 
Double Mutants, but Not Single Mutants, 
Are Sensitive to Radiomimetic Drugs 
It has been well documented that AT cells are sensitive 
to radiomimetic drugs, such as the peptides bleomycin 
(Lehmann and Stevens, 1979; Taylor et al., 1979) and the 
quinone-containing anti-tumor drug streptonigrin (Taylor 
et al., 1983). These agents act presumably by introducing 
a specific type of strand scission via a free radical attack 
on the deoxydbose moiety (Shiloh et al., 1983). To test 
the effects of radiomimetic drugs, we first determined a 
survival curve for wild-type yeast strains using a range of 
streptonigrin (5 ng/ml to 50 #g/ml) or bleomycin sulfate 
(10 ng/ml to 100 ~g/ml). Neither wild type nor either single 
mutant (tellA 1 or mecl-1) showed any difference in growth 
rate or viability at the highest concentrations tested (strep- 
tonigrin, 50 i~g/ml; bleomycin, 100 i~g/ml; data not shown). 
However, the tellA 1 mecl-1 double mutant died at 0.5 #,g/ 
ml of streptonigrin (Figure 5C) and 10 #g/ml of bleomycin 
(Figure 5D). The single mecl-1 TEL1 mutant is shown for 
comparison (0.5 ~,g/ml streptonigrin; Figure 5E). Some 
residual growth of the double mutants in both streptonigrin 
and bleomycin was seen before the cells died. However, 
when these double mutants were subsequently restreaked 
onto yeast extract-peptone-dextrose (YPD) plates, the 
cells were inviable, suggesting that irreversible damage to 
the cells had occurred. These data indicate that a common 
phenotype of AT cells, sensitivity to radiomimetic drugs, 
occurs only in S. cerevisiae tellA 1 mecl-1 double mutant 
cells. 
Discussion 
We have undertaken a study of the TEL1 gene, which 
is highly homologous to the ATM gene found mutated in 
patients with AT (Savitsky et al., 1995). Our primary pur- 
pose was to gain insight into the function of the ATM gene 
by studying its putative yeast homologs using recombinant 
genetic techniques. In this study we have demonstrated 
that a functional relationship exists between TEL1 and 
MECI. This was demonstrated by showing that an extra 
copy of TEL1 was able to rescue sensitivity of the mecl-1 
mutant to ionizing radiation, UV, and HU. TEL1 was also 
able to rescue viability of an otherwise lethal truncation 
of MECI. Although it is not yet known what the essential 
functions of MEC1 are, increased dosage of TEL1 can sub- 
stitute for them. Perhaps the strongest evidence for func- 
tional overlap between TEL1 and MEC1 comes from the 
analysis of double mutants, mecl-1 tellA 1 double mutants 
are more sensitive to ionizing radiation, UV, and HU than 
the mecl-1 mutant alone, indicating a synergistic interac- 
tion and a functional relationship. Of particular note, nei- 
ther mutant alone exhibited any sensitivity to radiomimetic 
drugs at the doses tested, but the double mutant was sen- 
sitive. 
One possible explanation of the interaction between 
TEL1 and MEC1 is that they are redundantly involved in 
the same checkpoint pathways, but that TEL1 provides 
only modest checkpoint function compared with MEC1. 
Alternatively, it is possible that TEL1 and MEC1 function 
in different but overlapping checkpoint pathways and that 
increased dosage of either protein can compensate for 
loss of function of the other. Perhaps, for example, the type 
of DNA lesion that induces the MEC1 checkpoint pathways 
differs from the lesion that induces the TEL1 checkpoint 
pathways; MEC1 could be involved primarily in damage 
induced by agents such as ionizing radiation or HU, 
whereas TEL1 might function to recognize other types of 
DNA damage (e.g., shorter or damaged telomeres). 
Which of these two S. cerevisiae genes is likely to be the 
true homolog of A TM (see Table 1)? Based on a BLASTP 
similarity search, TEL 1 appears to be the more likely can di- 
Table 1. Summary of AT Phenotypes versus Phenotypes of Mutant S. cerevisiae Homologs 
S. cerevisiae Homotog Phenotypes 
Phenotypes AT Patients tell A 1 mec1-1 tellA 1 mecl-1 
Sensitivity to ionizing radiation Yes No Yes Yes a 
Abnormal telomeres Yes Yes b No b Yes ~ 
Chromosome loss Yes Yes b ND ND 
Increased recombination Yes Yes b Yes ND 
Sensitivity to radiomimetic drugs Yes No No Yes 
Essential gene No No Yes -- 
Sensitivity to UV No No Yes Yes a 
Sensitivity to HU No No Yes Yes a 
Enhanced. 
b Data is from Greenwell et al. (1995): modest 
c Not enhanced. D. Tagle, unpublished ata. 
ND, not determined. 
increases (3- to 4-fold) were observed for chromosome loss and recombination. 
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date. Furthermore, when comparing the amino acid se- 
quence of ATM with that of Te l lp  or Mecl  p, it is apparent 
that disease-causing in-frame deletions in AT patients 
(Savitsky et al., 1995) are more conserved between A TM 
and TEL1 than with MEC1 (see Figure 1B). However,  
mecl-1 mutants display phenotypes consistent with being 
the functional homolog of ATM, including sensitivity to ion- 
izing radiation and defects in cell cycle arrest in response 
to DNA damage, mecl-1 mutants, however, also display 
additional phenotypes not characteristic of AT cells. For 
example,  MEC1 is essential for viability, and mecl-1 mu- 
tants are sensitive to both UV and HU. TEL1 mutants, 
on the other hand, that do not display these phenotypes 
display other phenotypes of AT cells (Pandita et al., 1995) 
that mecl-1 mutants do not; in particular, it has been noted 
that tell mutants exhibit altered telomere metabolism, in- 
cluding shortening of telomeres (Greenwell et al., 1995). 
This latter observation could explain the reduced life span 
and premature senescence seen in cell lines derived from 
AT patients. It is also well established that tumors have 
changes in both telomerase activity and in telomere length 
relative to their normal cellular counterparts that could ac- 
count for genomic instability (Kim et al., 1994; Murnane 
et al., 1994). In addition, TEL1 mutants also exhibit pheno- 
types common to AT cells, such as chromosome loss 
(Greenwell et al., 1995), whereas sensitivity to radiomi- 
metic drugs (at the doses tested) occurs only in te l l / l l  
mecl-1 double mutant strains. Finally, AT patients exhibit 
high rates of translocations, particularly within the T cell 
receptor and immunoglobul in heavy chain genes (re- 
viewed by Shiloh, 1995) and have been reported to have 
high rates of intrachromosomal recombination (Meyn, 
1993). Interestingly, mutations in either TEL1 (Greenwell 
et al., 1995) or MEC1/ESR1 (Kato and Ogawa, 1994) result 
in increased mitotic recombination. Thus, it appears that 
S. cerevisiae may not have a single functional homolog 
of ATM, but rather at least two nonallelic genes, TEL1 and 
MEC1, which might carry out separate but significantly 
overlapping functions. 
This is not an unprecedented situation. The NF1 gene 
responsible for the human genetic disorder neurofibro- 
matosis type 1 (Wallace et al., 1990), for example,  which 
plays an important role in catalyzing the conversion of 
rasGTP (the active form) to rasGDP (the inactive form), 
appears to have two related and partially redundant homo- 
logs in S. cerevisiae, IRA 1 and IRA2 (Tanaka et al., 1990; 
Ballester et al., 1990). In addition, Shani et al. (1995) have 
described two yeast genes (PXA1 and YXL741) that are 
homologous and functionally similar to X-l inked adreno- 
leukodystrophy in humans (Shani et al., 1995). In this case, 
mutations in either yeast gene cause phenotypes analo- 
gous to the human disease phenotype, suggesting the 
possibility of heteromeric interaction of protein subunits. 
The genetic analysis of TEL1 function presented here 
underscores the utility in identifying relationships between 
human genes and genes from other organisms to help us 
better understand the molecular basis of human disease. 
It is well established that human mutations leading to ge- 
nome instability can predispose an individual to cancer. 
Yeast, in particular, provides a powerful experimental  sys- 
tem for a thorough analysis of genes required for genomic 
stability, including those that function in control of cell cy- 
cle progression. The recent identification of' MSH2 and 
MLH1, the genes mutated in hereditary nonpolyposis co- 
lon cancer (Leach et al., 1993; Papadopoulos et al., 1994; 
Bronner et al., 1994; Reenan and Kolodner, 1992; Fishel et 
al., 1993; Prolla et al., 1994), via a cross-species candidate 
gene approach, and the subsequent cross-referencing of 
information gained in microbial systems about DNA mis- 
match repair to a basic understanding of colon cancer 
predisposition, demonstrates the value of yeast genetic 
studies to a basic understanding of cancer. Future genetic 
studies in yeast on TEL1 and MEC1 (as well as potential 
homologs yet to be discovered) may ult imately provide a 
basic understanding of cancer predisposition in AT pa- 
tients and heterozygous carriers. 
Experimental Procedures 
Yeast Strains and Yeast Transformation 
Yeast strains used in this study are listed in Table 2. Media and growth 
of yeast strains were as previously described (Rose et al., 1990). All 
yeast cultures were grown at 30°C. Transformation of yeast with DNA 
was performed by the lithium acetate procedure as previously de- 
scribed (Ito et al., 1983). For sensitivity studies, cells were grown over- 
night in YPD or minimal media and then reinoculated at OD600 = 0.1 
and grown to early- to middle-log phase (OD~ = 0.3-0.4) before use. 
For Figure 3, equal amounts of OD~ cells were irradiated in 3 ml of 
YPD at the doses indicated. Cell counts were taken, and 300 cells 
per plate were spread onto YPD plates. The number of ,cells surviving 
was determined 2-3 days later. For Figures 4 and 5, cells were grown 
as described above; cells were diluted to OD600 = 1.0, and dilution 
series were generated. We spotted 5 i11 of cells from each dilution 
onto YPD, or minimal media plates when selection for a plasmid was 
necessary, and irradiated the plates at the doses indicated. The num- 
ber of colony-forming units was determined 1 day later, and viability 
was calculated by comparison with unirradiated controls. 
Ionizing Radiation and UV Sensitivity Experiments 
Ionizing radiation experiments were performed with a Shepard Mark 
I ~37Cs irradiator at a strength of 0.675 kR per minute. UV experiments 
were performed with a Stratagene UV Stratalinker 2400. For HU 
(Sigma) experiments, cells were grown as described above, diluted 
back to OD600 = 0.2, and grown for an additional 4 hr at 30°C in the 
presence of 0.1 M HU. Cell counts were taken, and equal numbers 
of cells were plated onto YPD or minimal media plates. Colony-forming 
units were determined 2-3 days later. 
Radiomimetic Drug Studies 
Cells (10 ~1) in early- to middle-log phase were diluted into 100 ~1 of 
YPD, spread on YPD-agar plates, and grown for an additional 16 hr 
at 30°C. Colonies were replica plated onto either YPD plates without 
radiomimetic drugs or YPD plates containing bleomycin (Sigma; resus- 
pended at 10 mg/ml in H20)or streptonigrin (resuspended in dimethyl- 
formamide at 5 mg/ml). Plates were incubated at 30°C. 
tell and mecl  Mutant Strain Generation 
The te/l and mecl mutant strains were generated using the direct 
gene deletion technique previously described (Baudin et al., 1993). 
In brief, two oligonucleotides, each 60 nt in length, were generated; 
one oligonucleotide consists of 40 nt of sequence homologous to the 
5' region of the deletion to be generated, followed by 20 nt of sequence 
homologous to the pRS series of yeast shuttle vectors (Sikorski and 
Hieter, 1989). This sequence permits the amplification of any one of 
the yeast selectable markers cloned into the pRS vectors. The second 
oligonucleotide consists of 40 nt of sequence homologous to the 3' 
region of the deletion to be generated, followed by 20 nt of sequence 
from the opposing side of the selectable marker within the pRS vectors. 
The two oligonucleotides were used in a PCR to amplify the marker 
of choice from one of the pRS vectors (e.g., pRS3031HIS3). The PCR 
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Table 2. Strain List 
Name Genotypes Source 
YPH274 MATa/a ura3-52/ura3-52 his3A2OO/his3A200 ade2-101/ade2.101 This study 
leu2A 1/leu2d 1 lys2-801/lys2-801 trp l A 1/trpl A 1 
MATa/(~ tell A I : :HIS3/-rEL1 ura3-52_/ura3-52 his3A2OO/his3A200 
ade2-101/ade2-101 leu2A 1/leu2zl I lys2-801/lys2-801 trplA 1/trplA 1 
MATa tells41::HIS3 ura3-52 his3A200 ade2.101 leu2A 1 lys2-801 trplA 1 
MATe ura3-52 his3A200 ade2-101 leu2A1 lys2-801 trplA1 
MATa/~ tell A I : :HIS3/telI A 1::HIS3 ura3-52/ura3-52 his3A2OO/his3A200 
ade2-101/ade2-101 leu2A l/leu2A 1 lys2-801/lys2-801 trplA 1/trplA 1 
MATa ura3-52 his3A 200 ade2-101 leu2A1 lys2-801 trpI A1 
MATs tell A 1::HIS3 mecl.1 ura3.52 his3z1200 trpl A 1 
MATa tell A 1::HIS3 mec l-1 ura3-52 his3zl200 trp l A 1 
MATa tell A 1::HIS3 mecl-1 ura3.52 his34200 leu2A 1 lys2-801 trpl A 1 
MATe tellA 1::HIS3 mecl-1 ura3-52 his3zJ200 ade2-101 trplA 1 
As TWY308 + pDM197 
MATa tell A 15LA::HIS3 ura3-52 his3A200 ade2-101 leu2A 1 lys2-801 
trplA1 
MATa telIA3LA::HIS3 ura3-52 his3A200 ade2-101 leu2A 1 lys2-801 
trp l A1 
MATa tell A 103L O::HIS3 ura3-52 his3A200 ade2-101 leu2A 1 lys2-801 
trp 1A 1 
As TWY308 + pRS316 
MATa/(z mec1A15LA::HIS3/MEC1 ura3-52/ura3-52 his3A2OO/his3A200 
ade2-101/ade2-101 leu2A1/leu2A1 lys2-801/lys2-801 trplA1/trplA1 
MATc( mecl-1 ura3 trpl 
MATa ura3 his7 trpl leu2 
YDM881 
YDM884 
YDM885 
YDM890 
YDM911 
YDM935 
YDM936 
YDM937 
YDM938 
YDM939 
YDM950 
YDM951 
YDM952 
YDM959 
YDM966 
TWY308 
TWY397 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
Weinert et al. (1994) 
Weinert et al. (1994) 
product thus consists of linear double-stranded DNA containing the 
yeast selectable marker and 40 bp of sequence homologous to the 
region flanking the deletion to be generated. This PCR product is 
transformed into yeast cells, and homologous recombination replaces 
the region to be deleted with the selectable marker. In our experience, 
50%-80% of His + transformants in a his3A200 background are true 
deletions. The primers used for generating the tell and mecl deletion 
strains are listed in Table 3. All PCRs were performed on a Perkin 
Elmer 9600 using the following cycling protocol: one cycle for 2 min 
at 94°C; 30 cycles of 1 rain at 94"C, 1 rain at 50°C, and 2 min at 
72°C; followed by one cycle for 10 rain at 72°C. PCR amplification 
products were used directly in the transformations. 
Cloning of TEL1 
The TEL1 gene was cloned using a gap repair procedure (see Figure 
2B). First, the HIS3 gene and flanking sequence were amplified directly 
from YDM881 (telIAI::HIS31TEL1) cells using primers 1 and 4 listed 
in Table 3. The PCR was done for one cycle at 94°C; 35 cycles of 
1 min at 940C, 1 min at 45°C, and 2.5 min at 72°G; followed by one 
cycle for 10 min at 72°C. The 3.2 kb PCR product was gel purified, 
digested with EcoRI and Spel, and cloned into pRS316 (Sikorski and 
Hieter, 1989). The resulting plasmid, pDM196, was linearized with 
EcoR47111, which cuts within the HIS3 gene, and transformed into 
YPH274. Ura + colonies were replica plated onto minimal plates lacking 
histidine. The resulting Ura + His- colonies were selected and grown 
Table 3. Primers used in Generation of tell and mecl Deletion Strains and for the TEL1 Gap Repair Plasmid 
Name Primer Number Primer Sequence 
tell and mecl deletion strains 
tellA 1 2 
3 
telIAAT15LA 7 
3 
telIAA T3LA 6 
3 
telIAATIO3LO 5 
3 
meclAAT15LA 1 
2 
mec lAA TaLA 1 
2 
meclAAT103LO 1 
2 
TEL1 gap repair plasrnid primers 
5'-AAAGCCTTCAAAGAAAAGGGAAATCAGTGTAACATAGACGAGATTGTACTGAGAGTGCAC-3' 
5'-TATAAACAAAAAAAAGAA(3TATAAAGCATCTGCATAGCAACTGTGCGGTATTTCACACCG-3' 
5'-TTTGTCAGTGAACGAACCCTACAACTGCTGGCTAAGCAAATAAAGATTGTACTGAGAGTGCAC-3' 
5'-TATAAACAAAAAAAAGAAGTATAAAGCATCTGCATAGCAACTGTGCGGTATTTCACACCG-3' 
5'-ATCTATGGAGGAGAATGAATTTCAAAAGCCATTGCAACTATAAAGATTGTACTGAGAGTGCAC-3' 
5'-TATAAACAAAAAAAAGAAGTATAAAGCATCTGCATAGCAACTGTGCGGTATTTCACACCG-3' 
5'-ATACGAACACTTATTTGAAGAAGAACATGAAATTACAAATTAAAGATTGTACTGAGAGTGCAC-3' 
5'-TATAAACAAAAAAAAGAAGTATAAAGCATCTGCATAGCAACTGTGCGGTATTTCACACCG-3' 
5'-CGAAGTTTATGATTTGAATGATAGTGTTCAACTATTAAGTAAAGATTGTACTGAGAGTGCAC-3' 
5'-AAGAGGAAGTTCG TCTGTTGCCGAAAATGGTGGAAAGTCGC TGTCGGTATTTCACACCG-3' 
5'-ATTACATTCTCAT CAATCATCGGCCCA GATAATAATGCACTAAAGATTGTACTGA GAGTGCAC-3' 
5'-AAGAGGAAGTTCGTCTGTTGCCGAAAATGGTGGAAAGTCGCTGTCGGTATTTCACACCG-3' 
5'-AGCGTTGATGAATGTGATCGAAACAATTATGTACGATAGATAAAGATTGTACTGAGAGTGCAC-3' 
5'-AAGAGGAAGTTCGTCTGTTGCCGAAAATGGTGGAAAGTCGCTGTCGGTATTTCACACCG-3' 
1 5'-TGGTACCTCAC GGAGAT-3' 
4 5'-AAGAATGGTAG ATGTGC-3' 
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up in minimal media, plasmid DNA was isolated, and restriction analy- 
sis was done to determine which plasmid had a successfully gap- 
repaired TEL1 gene. 
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